Article ; Online: Nouvelle AMM : crizotinib dans les tumeurs myofibroblastiques inflammatoires pédiatriques ALK positives.
2023 Volume 110, Issue 3, Page(s) 248–249
Title translation | Drug approval: Crizotinib in unresectable or refractory ALK-positive pediatric inflammatory myofibroblastic tumors. |
---|---|
MeSH term(s) | Humans ; Child ; Crizotinib ; Drug Approval ; Anaplastic Lymphoma Kinase ; Protein Kinase Inhibitors ; Neoplasms |
Chemical Substances | Crizotinib (53AH36668S) ; Anaplastic Lymphoma Kinase (EC 2.7.10.1) ; Protein Kinase Inhibitors |
Language | French |
Publishing date | 2023-01-28 |
Publishing country | France |
Document type | Letter |
ZDB-ID | 213270-9 |
ISSN | 1769-6917 ; 0007-4551 |
ISSN (online) | 1769-6917 |
ISSN | 0007-4551 |
DOI | 10.1016/j.bulcan.2022.12.009 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Uh III Zs.15: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.